Showing results (311-320 of 334) with videos related to
Sort By:
Pageof 34
Journal for Immunotherapy of Cancer|May 21, 2026
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohortAnna-Sophia Mast, Peter Lang, Patrick Schlegel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaArend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, et al.Bone Marrow Transplantation|January 17, 2018
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell TransplantationStefan O Ciurea, Kai Cao, Marcelo Fernandez-Vina, et al.Haematologica|August 22, 2015
Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylationJoachim B Kunz, Tobias Rausch, Obul R Bandapalli, et al.Bone Marrow Transplantation|September 21, 2018
Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell TransplantationStefan O Ciurea, Kai Cao, Marcelo Fernandez-Vina, et al.Cell Host & Microbe|March 17, 2015
Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cellsNikolaus Rieber, Anurag Singh, Hasan Öz, et al.The New England Journal of Medicine|December 7, 2020
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaHaydar Frangoul, David Altshuler, M Domenica Cappellini, et al.The New England Journal of Medicine|June 26, 2009
Treating childhood acute lymphoblastic leukemia without cranial irradiationChing-Hon Pui, Dario Campana, Deqing Pei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II TrialTim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.The New England Journal of Medicine|April 24, 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-ThalassemiaFranco Locatelli, Peter Lang, Donna Wall, et al.Pageof 34